Experts in Preimplantation Genetic Diagnosis

Reprogenetics does not simply copy documented procedures and apply them to IVF Patients. Reprogenetics continues to innovate in order to provide better services for our patients. Towards this end, Reprogenetics maintains a strong focus on Technology, Research and Development. We are constantly monitoring our success rates and determining the best methods for increasing our outcomes. Moreover, we are consistently ahead of the curve with embracing and utilizing the newest technologies to improve screening for aneuploidies, chromosomal rearrangements and single-gene disorders.  Currently we run the following platforms:

Array Comparative Genomic Hybridzation (aCGH)

  • Preimplantation Genetic Screening (PGS) or Comprehensive Chromosome Screening (CCS)
  • Preimplantation Genetic Diagnosis (PGD) for Translocations and other chromosomal rearrangements
  • Products of Conception (POC)
  • Prenatal Diagnosis

SNP Arrays

  • PGD for single gene disorders and/or human leukocyte antigen (HLA) typing via Karyomapping
  • Carrier Screening -Recombine –

Next Generation Sequencing (NGS)

  • PGD (Clinical trials)
  • MiQ-Mitochondrial Quantification – Research and Development


  • PGD for Single Gene Disorders

Fluorescence In Situ Hybridization

  • PGD for Translocations not detectable by aCGH
  • Aneuploidy detection in sperm

Whole Genome Sequencing – Research Only